In patients undergoing angioplasty for femoropopliteal disease, use of a paclitaxel-eluting rather than an uncoated balloon can reduce late lumen loss and restenosis at 6 months and lessen the need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results